Drug target · HTR7
5-HT7
5-hydroxytryptamine receptor 7
2 compounds in the CNS pipeline act on 5-HT7.
Compounds targeting 5-HT7
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Brilaroxazine (RP5063)Small molecule | Antagonist | Ki 2.7 nM | Phase 3Schizophrenia | Reviva Pharmaceuticals Holdings, Inc. |
| LB-102 (N-methylamisulpride)Small molecule | Antagonist | Ki 31 nM | Phase 3Schizophrenia | LB Pharmaceuticals Inc. |